v3.26.1
ASSET ACQUISITION (Additional Information) (Details)
12 Months Ended
Dec. 31, 2025
USD ($)
shares
Asset Acquisition [Line Items]  
Common shares issued and reserved 401,126
Consideration transferred | $ $ 8,500,000
promissory note | $ 577,000
Salarius Pharmaceuticals [Member]  
Asset Acquisition [Line Items]  
Aggregated fair value | $ $ 4,302,000
Series A Stock  
Asset Acquisition [Line Items]  
Shares issued of Series A Non-Voting Convertible Preferred Stock 877.709
Convertible Preferred Stock Shares Reserved 796.306
Series B Stock  
Asset Acquisition [Line Items]  
Shares issued of Series A Non-Voting Convertible Preferred Stock 796.306
Nonvoting Common Stock [Member]  
Asset Acquisition [Line Items]  
Shares issued of Series A Non-Voting Convertible Preferred Stock 877.709